L

Life Science REIT PLC
LSE:LABS

Watchlist Manager
Life Science REIT PLC
LSE:LABS
Watchlist
Price: 42.5 GBX 0.95%
Market Cap: 148.8m GBX

Intrinsic Value

The intrinsic value of one LABS stock under the Base Case scenario is 50.91 GBX. Compared to the current market price of 42.5 GBX, Life Science REIT PLC is Undervalued by 17%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LABS Intrinsic Value
50.91 GBX
Undervaluation 17%
Intrinsic Value
Price
L
Worst Case
Base Case
Best Case

Valuation History
Life Science REIT PLC

What is Valuation History?
Compare LABS to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about LABS?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Life Science REIT PLC
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Life Science REIT PLC

Balance Sheet Decomposition
Life Science REIT PLC

Current Assets 12.1m
Cash & Short-Term Investments 5.6m
Receivables 3.1m
Other Current Assets 3.5m
Non-Current Assets 389m
Long-Term Investments 385.2m
Other Non-Current Assets 3.8m
Efficiency

Free Cash Flow Analysis
Life Science REIT PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Life Science REIT PLC

Revenue
20.3m GBP
Cost of Revenue
-5.9m GBP
Gross Profit
14.4m GBP
Operating Expenses
-4.8m GBP
Operating Income
9.6m GBP
Other Expenses
-23.6m GBP
Net Income
-14m GBP
Fundamental Scores

LABS Profitability Score
Profitability Due Diligence

Life Science REIT PLC's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Exceptional Operating Margin
Strong 3Y Average Operating Margin
Exceptional Gross Margin
Strong 3Y Average Gross Margin
45/100
Profitability
Score

Life Science REIT PLC's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

LABS Solvency Score
Solvency Due Diligence

Life Science REIT PLC's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Low Altman Z-Score
48/100
Solvency
Score

Life Science REIT PLC's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LABS Price Targets Summary
Life Science REIT PLC

Wall Street analysts forecast LABS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LABS is 37.74 GBX with a low forecast of 37.37 GBX and a high forecast of 38.85 GBX.

Lowest
Price Target
37.37 GBX
12% Downside
Average
Price Target
37.74 GBX
11% Downside
Highest
Price Target
38.85 GBX
9% Downside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for LABS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

LABS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one LABS stock?

The intrinsic value of one LABS stock under the Base Case scenario is 50.91 GBX.

Is LABS stock undervalued or overvalued?

Compared to the current market price of 42.5 GBX, Life Science REIT PLC is Undervalued by 17%.

Back to Top